Adamczyk, B., Wawrzyniak, S., Kasperczyk, S., Adamczyk-Sowa, M., 2017. The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy. Oxid. Med. Cell. Longev. 2017. https://doi.org/10.1155/2017/9625806
Borisovs, V., Ļeonova, E., Baumane, L., Kalniņa, J., Mjagkova, N., Sjakste, N., 2019. Blood levels of nitric oxide and DNA breaks assayed in whole blood and isolated peripheral blood mononucleated cells in patients with multiple sclerosis. Mutat. Res. Toxicol. Environ. Mutagen., The Comet assay – Human biomonitoring 843, 90–94. https://doi.org/10.1016/j.mrgentox.2018.11.008
Collins, A.R., Dusinská, M., Gedik, C.M., Stĕtina, R., 1996. Oxidative damage to DNA: do we have a reliable biomarker? Environ. Health Perspect. 104, 465–469.
Collins, A. R., Duthie, S.J., Dobson, V.L., 1993. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 14, 1733–1735. https://doi.org/10.1093/carcin/14.9.1733
Collins, Andrew R., Duthie, S.J., Dobson, V.L., 1993. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 14, 1733–1735. https://doi.org/10.1093/carcin/14.9.1733
Collins, A.R., Fleming, I.M., Gedik, C.M., 1994. In vitro repair of oxidative and ultraviolet-induced DNA damage in supercoiled nucleoid DNA by human cell extract. Biochim. Biophys. Acta BBA - Gene Struct. Expr. 1219, 724–727. https://doi.org/10.1016/0167-4781(94)90236-4
Esterbauer, H., Schaur, R.J., Zollner, H., 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81–128. https://doi.org/10.1016/0891-5849(91)90192-6
Fiorini, A., Koudriavtseva, T., Bucaj, E., Coccia, R., Foppoli, C., Giorgi, A., Schininà, M.E., Domenico, F.D., Marco, F.D., Perluigi, M., 2013. Involvement of Oxidative Stress in Occurrence of Relapses in Multiple Sclerosis: The Spectrum of Oxidatively Modified Serum Proteins Detected by Proteomics and Redox Proteomics Analysis. PLOS ONE 8, e65184. https://doi.org/10.1371/journal.pone.0065184
Fominykh, V., Onufriev, M.V., Vorobyeva, A., Brylev, L., Yakovlev, A.A., Zakharova, M.N., Gulyaeva, N.V., 2016. Increased S-nitrosothiols are associated with spinal cord injury in multiple sclerosis. J. Clin. Neurosci. 28, 38–42. https://doi.org/10.1016/j.jocn.2015.09.017
Ghasemi, N., Razavi, S., Nikzad, E., 2017. Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy. Cell J. Yakhteh 19, 1–10.
Giovannoni, G., Heales, S.J., Silver, N.C., O’Riordan, J., Miller, R.F., Land, J.M., Clark, J.B., Thompson, E.J., 1997. Raised serum nitrate and nitrite levels in patients with multiple sclerosis. J. Neurol. Sci. 145, 77–81. https://doi.org/10.1016/s0022-510x(96)00246-8
Goldenberg, M.M., 2012. Multiple Sclerosis Review. Pharm. Ther. 37, 175–184.
Gonsette, R.E., 2008. Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity. J. Neurol. Sci. 274, 48–53. https://doi.org/10.1016/j.jns.2008.06.029
Haghikia, Aiden, Kayacelebi, A.A., Beckmann, B., Hanff, E., Gold, R., Haghikia, Arash, Tsikas, D., 2015. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica. Amino Acids 47, 1837–1845. https://doi.org/10.1007/s00726-015-2015-0
Hinokio, Y., Suzuki, S., Hirai, M., Chiba, M., Hirai, A., Toyota, T., 1999. Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia 42, 995–998. https://doi.org/10.1007/s001250051258
Kalincik, T., 2015. Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review. Neuroepidemiology 44, 199–214. https://doi.org/10.1159/000382130
Kuchařová, M., Hronek, M., Rybáková, K., Zadák, Z., Štětina, R., Josková, V., Patková, A., 2019. Comet assay and its use for evaluating oxidative DNA damage in some pathological states. Physiol. Res. 68, 1–15. https://doi.org/10.33549/physiolres.933901
Kumar, A., Chen, S.-H., Kadiiska, M.B., Hong, J.-S., Zielonka, J., Kalyanaraman, B., Mason, R.P., 2014. Inducible nitric oxide synthase is key to peroxynitrite-mediated, LPS-induced protein radical formation in murine microglial BV2 cells. Free Radic. Biol. Med. 73, 51–59. https://doi.org/10.1016/j.freeradbiomed.2014.04.014
Lan, M., Tang, X., Zhang, J., Yao, Z., 2018. Insights in pathogenesis of multiple sclerosis: nitric oxide may induce mitochondrial dysfunction of oligodendrocytes. Rev. Neurosci. 29, 39–53. https://doi.org/10.1515/revneuro-2017-0033
Lublin, F.D., Reingold, S.C., Cohen, J.A., Cutter, G.R., Sørensen, P.S., Thompson, A.J., Wolinsky, J.S., Balcer, L.J., Banwell, B., Barkhof, F., Bebo, B., Calabresi, P.A., Clanet, M., Comi, G., Fox, R.J., Freedman, M.S., Goodman, A.D., Inglese, M., Kappos, L., Kieseier, B.C., Lincoln, J.A., Lubetzki, C., Miller, A.E., Montalban, X., O’Connor, P.W., Petkau, J., Pozzilli, C., Rudick, R.A., Sormani, M.P., Stüve, O., Waubant, E., Polman, C.H., 2014. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83, 278–286. https://doi.org/10.1212/WNL.0000000000000560
Magyari, M., Sorensen, P.S., 2019. The changing course of multiple sclerosis: rising incidence, change in geographic distribution, disease course, and prognosis. Curr. Opin. Neurol. 32, 320–326. https://doi.org/10.1097/WCO.0000000000000695
Milic, M., Frustaci, A., Del Bufalo, A., Sánchez-Alarcón, J., Valencia-Quintana, R., Russo, P., Bonassi, S., 2015. DNA damage in non-communicable diseases: A clinical and epidemiological perspective. Mutat. Res. 776, 118–127. https://doi.org/10.1016/j.mrfmmm.2014.11.009
Miller, E., Walczak, A., Saluk, J., Ponczek, M.B., Majsterek, I., 2012. Oxidative modification of patient’s plasma proteins and its role in pathogenesis of multiple sclerosis. Clin. Biochem. 45, 26–30. https://doi.org/10.1016/j.clinbiochem.2011.09.021
Noroozi, S., Arababadi, M.K., Meimand, H.A.E., Asadikaram, G., 2017. The Effect of IFN-beta 1a on Biochemical Factors in Multiple Sclerosis Patients. Iran. Red Crescent Med. J. 19, 8.
Rosenblum, E.R., Gavaler, J.S., Van Thiel, D.H., 1989. Lipid peroxidation: a mechanism for alcohol-induced testicular injury. Free Radic. Biol. Med. 7, 569–577. https://doi.org/10.1016/0891-5849(89)90034-8
Saif Eldeen, E.M.S., El Sharkawy, R., Abd El Azim, G., Mohamed, N., Abd Elmajed, M., 2019. Role of nitric oxide and malondialdehyde biomarkers in relapsing-remitting multiple sclerosis. Sci. J. Al-Azhar Med. Fac. Girls 3, 544. https://doi.org/10.4103/sjamf.sjamf_59_19
Souliotis, V.L., Vlachogiannis, N.I., Pappa, M., Argyriou, A., Ntouros, P.A., Sfikakis, P.P., 2019. DNA Damage Response and Oxidative Stress in Systemic Autoimmunity. Int. J. Mol. Sci. 21. https://doi.org/10.3390/ijms21010055
Stadelmann, C., Wegner, C., Brück, W., 2011. Inflammation, demyelination, and degeneration — Recent insights from MS pathology. Biochim. Biophys. Acta BBA - Mol. Basis Dis., Molecular Basis of Multiple Sclerosis 1812, 275–282. https://doi.org/10.1016/j.bbadis.2010.07.007
Thompson, A.J., Banwell, B.L., Barkhof, F., Carroll, W.M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M.S., Fujihara, K., Galetta, S.L., Hartung, H.P., Kappos, L., Lublin, F.D., Marrie, R.A., Miller, A.E., Miller, D.H., Montalban, X., Mowry, E.M., Sorensen, P.S., Tintoré, M., Traboulsee, A.L., Trojano, M., Uitdehaag, B.M.J., Vukusic, S., Waubant, E., Weinshenker, B.G., Reingold, S.C., Cohen, J.A., 2018. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162–173. https://doi.org/10.1016/S1474-4422(17)30470-2
Trapp, B.D., Nave, K.-A., 2008. Multiple sclerosis: an immune or neurodegenerative disorder? Annu. Rev. Neurosci. 31, 247–269. https://doi.org/10.1146/annurev.neuro.30.051606.094313
Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R.A., Robertson, N., La Rocca, N., Uitdehaag, B., van der Mei, I., Wallin, M., Helme, A., Angood Napier, C., Rijke, N., Baneke, P., 2020. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult. Scler. Houndmills Basingstoke Engl. 26, 1816–1821. https://doi.org/10.1177/1352458520970841
Weiner, H.L., 2008. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J. Neurol. 255 Suppl 1, 3–11. https://doi.org/10.1007/s00415-008-1002-8